Patent details

EP1667521 Title: METHODS FOR TREATMENT OF INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) DEFICIENCY

  • Data
  • Documents

Basic Information

Publication number:
EP1667521
PCT Application Number:
PCT/US/2004/029735
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP048177646
PCT Publication Number:
WO/2005/049792
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS FOR TREATMENT OF INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) DEFICIENCY
French Title of Invention:
METHODES DE TRAITEMENT DE LA DEFICIENCE DU FACTEUR DE CROISSANCE DE TYPE INSULINE 1 (IGF-1)
German Title of Invention:
VERFAHREN ZUR BEHANDLUNG VON IGF-1 (INSULIN-LIKE GROWTH FACTOR 1)-MANGEL
SPC Number:

Dates

Filing date:
09/09/2004
Grant date:
07/12/2011
EP Publication Date:
07/12/2011
PCT Publication Date:
02/06/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/06/2006
EP B1 Publication Date:
07/12/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/09/2012
Expiration date:
09/09/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/09/2004
 
 

Name:
Tercica Inc.
Address:
2000 Sierra Point Parkway, Suite 400, Brisbane, CA 94005, United States (US)

Inventor

Name:
CLARK Ross G.
Address:
New Zealand (NZ)

Priority

Priority Number:
502579 P
Priority Date:
12/09/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/30;